The Utility of the Myriad myRisk Hereditary Cancer Test

January 17, 2014
Elizabeth Garner, MD, MPH

Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the Myriad myRisk Hereditary Cancer Test.

Clinical Pearls

Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the Myriad myRisk Hereditary CancerTMTest.

  • MyRisk is a genetic test that looks for mutations in 25 genes that are known to be associated with significantly elevated risk for cancer
  • There are eight major cancers the test can detect, including breast cancer, ovarian cancer, melanoma, and endometrial cancer.
  • The test allows physicians to increase the rate of detection for individuals that have mutations or who have hereditary cancer syndromes